CSIMarket
 


Arcus Biosciences Inc   (RCUS)
Other Ticker:  
 

Arcus Biosciences Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Arcus Biosciences Inc in the forth quarter 2023?
Arcus Biosciences Inc recorded a cumulative net loss of $-307 million during 12 months ending in the forth quarter 2023, resulting in a negative return on equity (ROE) of -57.17%.

Within the Major Pharmaceutical Preparations industry 35 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 952, from total ROE ranking in the third quarter 2023 at 2760.

What is ROE?



Return On Equity (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Change -29.68 % -25.58 % -24.27 % -24.68 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -307 -293 -287 -279 -267
Return On Equity (TTM) -57.17 % -50.1 % -45.58 % -41.29 % -36.83 %
RCUS's Total Ranking # 952 # 2760 # 3178 # 3092 # 3287
Equity (TTM) in Millions 462 520 566 600 657
Seq. Equity Change -11.15 % -8.13 % -5.67 % -8.68 % -5.97 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry # 36
Sector # 102
Overall # 952

Return On Equity Statistics
High Average Low
10.35 %
-29.01 %
-57.17 %
(Sep 30 2022)   (Dec 31 2023)





RCUS Annual Return On Equity (Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
Total Equity in Millions 462 657 841 502 164
Y / Y Equity Change -29.68 % -21.92 % 67.52 % 206.58 % -
Net Income in Millions -307 -267 53 -123 -85
Y / Y Net Income Change - - - - -
Return On Equity -66.45 % -40.64 % 6.28 % -24.46 % -51.7 %





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RCUS's' Return on Equity at Yahoo Finance
RCUS's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for RCUS's Competitors
Return On Equity for Arcus Biosciences Inc 's Suppliers
Roe for RCUS's Customers




Companies with similar Return On Equity at Dec 31 2023, within Healthcare Sector ROE


Date modified: 2024-02-22T08:37:21+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com